REVVITY, INC (RVTY) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
54/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinRVTY / S&P 27.09% / 15.20% |
LoseRVTY / S&P 4.05% / 15.00% |
LoseRVTY / S&P -11.44% / 50.40% |
| 2026-Q10/3 |
LoseRVTY / S&P -9.39% / -4.33% |
LoseRVTY / S&P 4.79% / 11.30% |
LoseRVTY / S&P -11.49% / 27.70% |
| 2025-Q41/3 |
WinRVTY / S&P 10.46% / 2.65% |
LoseRVTY / S&P 3.67% / 9.00% |
LoseRVTY / S&P -6.33% / 13.40% |
| 2025-Q30/3 |
LoseRVTY / S&P -9.31% / 8.12% |
LoseRVTY / S&P 3.37% / 4.61% |
LoseRVTY / S&P -4.33% / 13.45% |
| 2025-Q21/3 |
LoseRVTY / S&P -8.51% / 10.94% |
LoseRVTY / S&P 3.33% / 4.83% |
WinRVTY / S&P 69.78% / 10.63% |
| 2025-Q11/3 |
LoseRVTY / S&P -5.15% / -4.27% |
LoseRVTY / S&P 1.62% / 4.98% |
WinRVTY / S&P 92.62% / 10.57% |
| 2024-Q40/3 |
LoseRVTY / S&P -12.58% / 2.41% |
LoseRVTY / S&P 0.16% / 5.25% |
LoseRVTY / S&P -59.89% / 6.15% |
| 2024-Q31/3 |
WinRVTY / S&P 21.91% / 5.89% |
LoseRVTY / S&P -2.66% / 5.89% |
LoseRVTY / S&P -64.57% / 6.11% |
| 2024-Q20/3 |
LoseRVTY / S&P -0.06% / 4.28% |
LoseRVTY / S&P -4.54% / 5.38% |
LoseRVTY / S&P -78.48% / 5.12% |
| 2024-Q10/3 |
LoseRVTY / S&P -3.88% / 10.56% |
LoseRVTY / S&P -9.85% / 5.71% |
LoseRVTY / S&P -83.95% / 5.59% |
| 2023-Q41/3 |
LoseRVTY / S&P -1.19% / 11.69% |
LoseRVTY / S&P -16.95% / 6.81% |
WinRVTY / S&P 22.44% / 7.78% |
| 2023-Q31/3 |
LoseRVTY / S&P -6.76% / -3.27% |
LoseRVTY / S&P -22.30% / 7.52% |
WinRVTY / S&P 19.31% / -5.03% |
| 2023-Q21/3 |
LoseRVTY / S&P -10.81% / 8.74% |
LoseRVTY / S&P -24.31% / 9.50% |
WinRVTY / S&P 20.52% / -8.57% |
| 2023-Q11/3 |
LoseRVTY / S&P -4.91% / 7.50% |
LoseRVTY / S&P -25.91% / 10.77% |
WinRVTY / S&P 23.98% / -15.69% |
| 2022-Q41/3 |
WinRVTY / S&P 16.59% / 7.56% |
LoseRVTY / S&P -25.16% / 11.88% |
LoseRVTY / S&P -44.44% / -17.99% |
| 2022-Q30/3 |
LoseRVTY / S&P -15.35% / -4.88% |
LoseRVTY / S&P -0.94% / 13.47% |
LoseRVTY / S&P -51.09% / -1.41% |
| 2022-Q20/3 |
LoseRVTY / S&P -18.45% / -16.10% |
LoseRVTY / S&P 0.34% / 13.71% |
LoseRVTY / S&P -49.05% / 11.04% |
| 2022-Q11/3 |
LoseRVTY / S&P -13.20% / -4.60% |
WinRVTY / S&P 22.97% / 15.97% |
LoseRVTY / S&P -35.88% / 42.23% |
| 2021-Q42/3 |
WinRVTY / S&P 16.07% / 11.03% |
WinRVTY / S&P 66.17% / 15.00% |
LoseRVTY / S&P 24.81% / 96.40% |
| 2021-Q33/3 |
WinRVTY / S&P 12.28% / 0.58% |
WinRVTY / S&P 12.34% / 10.77% |
WinRVTY / S&P 173.37% / 69.42% |
| 2021-Q23/3 |
WinRVTY / S&P 20.42% / 8.55% |
WinRVTY / S&P 25.49% / 6.58% |
WinRVTY / S&P 300.00% / 51.81% |
| 2021-Q12/3 |
LoseRVTY / S&P -10.56% / 6.17% |
WinRVTY / S&P 14.93% / -1.06% |
WinRVTY / S&P 373.27% / 7.39% |
| 2020-Q42/3 |
WinRVTY / S&P 14.40% / 12.15% |
LoseRVTY / S&P -7.64% / -3.72% |
WinRVTY / S&P 218.14% / -33.42% |
| 2020-Q33/3 |
WinRVTY / S&P 28.04% / 8.93% |
WinRVTY / S&P 14.08% / -2.04% |
WinRVTY / S&P 75.24% / -27.10% |
| 2020-Q23/3 |
WinRVTY / S&P 30.42% / 20.54% |
WinRVTY / S&P 6.23% / -0.46% |
WinRVTY / S&P 15.86% / -27.11% |
| 2020-Q12/3 |
LoseRVTY / S&P -22.42% / -19.60% |
WinRVTY / S&P 3.76% / 3.47% |
WinRVTY / S&P -9.01% / -14.75% |
| 2019-Q41/3 |
WinRVTY / S&P 14.11% / 9.07% |
LoseRVTY / S&P 3.80% / 5.36% |
LoseRVTY / S&P -4.23% / 2.99% |
| 2019-Q32/3 |
LoseRVTY / S&P -11.53% / 1.70% |
WinRVTY / S&P 6.43% / 5.02% |
WinRVTY / S&P 89.19% / 0.21% |
| 2019-Q22/3 |
LoseRVTY / S&P 0.05% / 4.30% |
WinRVTY / S&P 10.17% / 6.64% |
WinRVTY / S&P 83.06% / 8.65% |
| 2019-Q12/3 |
WinRVTY / S&P 22.78% / 13.65% |
WinRVTY / S&P 16.59% / 8.12% |
LoseRVTY / S&P -11.55% / 14.29% |
| 2018-Q41/3 |
LoseRVTY / S&P -19.18% / -13.52% |
WinRVTY / S&P 23.08% / 9.05% |
LoseRVTY / S&P -19.01% / 18.23% |
| 2018-Q32/3 |
WinRVTY / S&P 32.95% / 7.71% |
WinRVTY / S&P 22.05% / 10.21% |
LoseRVTY / S&P -69.08% / 19.06% |
| 2018-Q21/3 |
LoseRVTY / S&P -3.20% / 3.43% |
WinRVTY / S&P 18.71% / 9.03% |
LoseRVTY / S&P -62.42% / 14.46% |
| 2018-Q13/3 |
WinRVTY / S&P 3.65% / -0.76% |
WinRVTY / S&P 11.97% / 7.68% |
WinRVTY / S&P 23.04% / 12.46% |
| 2017-Q41/3 |
LoseRVTY / S&P 6.12% / 6.64% |
LoseRVTY / S&P 6.69% / 7.03% |
WinRVTY / S&P 24.06% / 13.82% |
| 2017-Q32/3 |
LoseRVTY / S&P 1.32% / 4.48% |
WinRVTY / S&P 9.14% / 5.68% |
WinRVTY / S&P 67.76% / 17.57% |
| 2017-Q22/3 |
WinRVTY / S&P 17.50% / 3.09% |
LoseRVTY / S&P 4.59% / 4.83% |
WinRVTY / S&P 57.89% / 17.74% |
| 2017-Q11/3 |
WinRVTY / S&P 11.48% / 6.07% |
LoseRVTY / S&P 2.68% / 3.67% |
LoseRVTY / S&P 5.15% / 13.32% |
| 2016-Q41/3 |
LoseRVTY / S&P -6.94% / 3.82% |
LoseRVTY / S&P 0.51% / 2.09% |
WinRVTY / S&P 13.37% / 7.05% |
| 2016-Q32/3 |
WinRVTY / S&P 7.18% / 3.85% |
LoseRVTY / S&P -4.58% / 0.20% |
WinRVTY / S&P 38.96% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | RVTY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 44.34% | 20.78% |
| Annualized return | 44.34% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | RVTY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -30.18% | 83.14% |
| Annualized return | -6.93% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | RVTY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 150.64% | 319.30% |
| Annualized return | 9.62% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |